A Double-Blind, Randomized, Placebo-Controlled Study of Quetiapine as Adjunctive Treatment for Adolescent Mania

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 41, Issue 10, 2002, Pages 1216-1223

  DelBello, Melissa P ^a   Schwiers, Michael L ^a   Rosenberg, H Lee ^a   Strakowski, Stephen M ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Adolescent; Bipolar disorder; Mania; Quetiapine

Indexed keywords

PLACEBO; PROLACTIN; QUETIAPINE; THYROTROPIN; VALPROATE SEMISODIUM; DIBENZOTHIAZEPINE DERIVATIVE; TRANQUILIZER; VALPROIC ACID;

ADOLESCENT; ARTHRALGIA; ARTICLE; BIPOLAR DISORDER; CATARACT; CHILD PSYCHIATRY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; MALE; MANIA; NAUSEA; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SEDATION; VOMITING; XEROSTOMIA; ACUTE DISEASE; ANALYSIS OF VARIANCE; CHILD; DRUG COMBINATION;

ACUTE DISEASE; ADOLESCENT; ANALYSIS OF VARIANCE; ANTIMANIC AGENTS; BIPOLAR DISORDER; CHILD; DIBENZOTHIAZEPINES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; VALPROIC ACID;

EID: 0036781742     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-200210000-00011     Document Type: Article

References (46)

1. Barnes TR (1989), A rating scale for drug-induced akathisia. Br J Psychiatry 154:672-676
2. Bowden CL, Brugger AM, Swann AC et al. (1994), Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA 271:918-924
3. Catapano-Friedman L (2001), Effectiveness of quetiapine in the management of psychotic depression in an adolescent boy with bipolar disorder, mixed, with psychosis. J Child Adolesc Psychopharmacol 11:205-206
4. Chang KD, Ketter TA (2000), Mood stabilizer augmentation with olanzapine in acutely manic children. J Child Adolesc Psychopharmacol 10:45-49
5. Cohen L (1988), Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Erlbaum
6. DelBello MP, Soutullo CA, Hendricks W, Niemeier RT, McElroy SL, Strakowski SM (2001), Prior stimulant treatment in adolescents with bipolar disorder: association with age at onset. Bipolar Disord 3:53-57
7. Demir E, Aysun S (2000), Weight gain associated with valproate in childhood. Pediatr Neurol 22:361-364
8. Dev V, Raniwalla J (2000), Quetiapine: a review of its safety in the management of schizophrenia. Drug Saf 23:295-307
9. Dunayevich E, Strakowski SM (2000), Quetiapine for treatment-resistant mania. Am J Psychiatry 157:1341
10. Frazier JA, Biederman J, Tohen M et al. (2001), A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 11:239-250
11. Frazier JA, Meyer MC, Biederman J et al. (1999), Risperidone treatment for juvenile bipolar disorder: a retrospective chart review. J Am Acad Child Adolesc Psychiatry 38:960-965
12. Fristad MA, Weller EB, Weller RA (1992), The Mania Rating Scale: can it be used in children? A preliminary report. J Am Acad Child Adolesc Psychiatry 31:252-257
13. Geller B, Cooper TB, Sun K et al. (1998), Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry 37:171-178
14. Geller B, Zimerman B, Williams M et al. (2000), Diagnostic characteristics of 93 cases of a prepubertal and early adolescent bipolar disorder phenotype by gender, puberty and comorbid attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 10:157-164
15. Geller B, Zimerman B, Williams M et al. (2001), Reliability of the Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-U-KSADS) mania and rapid cycling sections. J Am Acad Child Adolesc Psychiatry 40:450-455
16. Ghaemi SN, Katzow JJ (1999), The use of quetiapine for treatment-resistant bipolar disorder: a case series. Ann Clin Psychiatry 11:137-140
17. Guy W (1976), Abnormal Involuntary Movement Scale. ECDEU Assessment Manual for Psychopharmacology, revised edition. Rockville, MD: US Department of Health, Education, and Welfare
18. Jones HM, Travis MJ, Mulligan R et al. (2001), In vivo 5-HT2A receptor blockade by quetiapine: an R91150 single photon emission tomography study. Psychopharmacology (Berl) 157:60-66
19. Kasper S, Muller-Spahn F (2000), Review of quetiapine and its clinical applications in schizophrenia. Expert Opin Pharmacother 1:783-801
20. Kay SR, Opler LA, Lindenmayer JP (1989), The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. Br J Psychiatry Suppl 7:59-67
21. Kearns AE, Goff DC, Hayden DL, Daniels GH (2000), Risperidone-associated hyperprolactinemia. Endocr Pract 6:425-429
22. Kowatch RA, Suppes T, Carmody TJ et al. (2000), Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 39:713-720
23. Kowatch RA, Suppes T, Gilfillan SK, Fuentes RM, Grannemann BD, Emslie GJ (1995), Clozapine treatment of children and adolescents with bipolat disorder and schizophrenia: a clinical case series. J Child Adolesc Psychopharmacol 5:241-253
24. Lish JD, Dime-Meenan S, Whybrow PC, Price RA, Hirschfeld RM (1994), The National Depressive and Manic-Depressive Association (DMDA) survey of bipolar members. J Affect Disord 31:281-294
25. McConville BJ, Arvanitis LA, Thyrum PT et al. (2000), Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumatate: an open-label trial in adolescents with psychotic disorders. J Clin Psychiatry 61:252-260
26. McElroy SL, Keck PE Jr (2000), Pharmacologic agents for the treatment of acute bipolar mania. Biol Psychiatry 48:539-557
27. McIntyre RS, McCann SM, Kennedy SH (2001), Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities. Can J Pychiatry 46:273-281
28. Morris N, Udry J (1980), Validation of a self-administered instrument to assess stage of adolescent development. J Youth Adolesc Dev 9:271-280
29. Padla D (2001), Quetiapine resolves psychotic depression in an adolescent boy. J Child Adolesc Psychopharmacol 11:207-208
30. Poznanski EO, Cook SC, Carroll BJ (1979), A depression rating scale for children. Pediatrics 64:442-450
31. Poznanski EO, Cook SC, Carroll BJ, Corzo H (1983), Use of the Children's Depression Rating Scale in an inpatient psychiatric population. J Clin Psychiatry 44:200-203
32. Schaller JL, Behar D (1999), Quetiapine for refractory mania in a child. J Am Acad Child Adolesc Psychiatry 38:498-499
33. Segal J, Berk M, Brook S (1998), Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Clin Neuropharmacol 21:176-180
34. Selva KA, Scort SM (2001), Diabetic ketoacidosis associated with olanzapine in an adolescent patient. J Pediatr 138:936-938
35. Shaffer D, Gould MS, Brasic J et al. (1983), A children's global assessment scale (CGAS). Arch Gen Psychiatry 40:1228-1231
36. Simpson GM, Angus JW (1970), A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 212:11-19
37. Soutullo CA, Sorter MT, Foster KD, McElroy SL, Keck PE (1999), Olanzapine in the treatment of adolescent acute mania: a report of seven cases. J Affect Disord 53:279-283
38. Stevens J (1990), Intermediate Statistics: A Modern Approach. Hillsdale, NJ: Erlbaum
39. Swann AC, Bowden CL, Morris D et al. (1997), Depression during mania: treatment response to lithium or divalproex. Arch Gen Psychiatry 54:37-42
40. Tohen M, Chengappa KN, Suppes T et al. (2002), Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry 59:62-69
41. Tohen M, Jacobs TG, Grundy SL et al. (2000), Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzapine HGGW Study Group. Arch Gen Psychiatry 57:841-849
42. Tohen M, Sanger TM, McElroy SL et al. (1999), Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am J Psychiatry 156:702-709
43. West S, Keck P, McElroy S (1995), Oral loading doses in the valproate treatment of adolescents with mixed bipolar disorder. J Child Adolesc Psychopharmacol 5:225-231
44. Young RC, Biggs JT, Ziegler VE, Meyer DA (1978), A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429-435
45. Zaratc CA Jr, Rothschild A, Fletcher KE, Madrid A, Zapatel J (2000), Clinical predictors of acute response with quetiapine in psychotic mood disorders. J Clin Psychiatry 61:185-189
46. Zuddas A, Di Martino A, Muglia P, Cianchetti C (2000), Long-term risperidone for pervasive developmental disorder: efficacy, tolerability, and discontinuation. J Child Adolesc Psychopharmacol 10:79-90